Shattuck Labs, Inc.

US$4.62As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:STTKHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (24.87%)
Div yield —
ROE (47.20%)
Biotechnology
Beta (5Y) 1.13
PE TTM —
TSR TTM 140.62%
Mkt cap US$470.5M
ROIC (30.84%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.58
20.71%
(93.36%)
Hold 6|4|6|9|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.10
0.10
0.10
6.81%
17.52%
13.53%
1.49%
Revenue$M
24.20
24.15
24.05
24.39
5.63%
7.84%
3.08%
6.77%
Peers (US$470.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.757
0.126
0.101
EBIT/Intx
0.895
1.087
1.024
Own earn%
(95.21)
(44.98)
(49.33)
Sh yield%
21.00
59.29
58.63
Owners
Insiders/Inst%
4.89
26.43
Short interest%
3.40
SBC / revenue%
3.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
7–17
$1 testx
—
Incr. ROIC%
3